相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。S-Nitrosylation of Histone Deacetylase 2 by Neuronal Nitric Oxide Synthase as a Mechanism of Diastolic Dysfunction
Somy Yoon et al.
CIRCULATION (2021)
Global Differences in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial
Jasper Tromp et al.
CIRCULATION-HEART FAILURE (2021)
Endothelium-mediated contributions to fibrosis
Xuetao Sun et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Research Priorities for Heart Failure With Preserved Ejection Fraction National Heart, Lung, and Blood Institute Working Group Summary
Sanjiv J. Shah et al.
CIRCULATION (2020)
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
Jin Ma et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
MD1 deletion exaggerates cardiomyocyte autophagy induced by heart failure with preserved ejection fraction through ROS/MAPK signalling pathway
Hong-Jie Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis
Sara Lovisa et al.
SCIENCE SIGNALING (2020)
Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
Christopher J. Charles et al.
ANIMALS (2020)
Cardiorenal syndrome in heart failure with preserved ejection fractionan under-recognized clinical entity
Akanksha Agrawal et al.
HEART FAILURE REVIEWS (2019)
Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation
Takeo Tsutsumi et al.
PLOS ONE (2019)
Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice
Tzu-Hsien Tsai et al.
CELLS (2019)
Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats
Xingxing Chen et al.
LIFE SCIENCES (2019)
Kidney transplantation is associated with reduced myocardial fibrosis. A cardiovascular magnetic resonance study with native T1 mapping
Mariana Moraes Contti et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2019)
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
Koen W. Streng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Cardiac macrophages promote diastolic dysfunction
Maarten Hulsmans et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Cardiorenal Syndrome Revisited
Faiez Zannad et al.
CIRCULATION (2018)
Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition
Toshio Suzuki et al.
RESPIRATORY RESEARCH (2017)
The role of PDGF-B/TGF-β1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling
Shasha Song et al.
CELLULAR SIGNALLING (2016)
Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome
Christian G. M. van Dijk et al.
CIRCULATION-HEART FAILURE (2016)
Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction
Maria Valero-Munoz et al.
CIRCULATION-HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Sonsoles Piera-Velazquez et al.
JOURNAL OF CLINICAL MEDICINE (2016)
The kidney in heart failure: an update
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2015)
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist
Paola Cipriani et al.
JOURNAL OF RHEUMATOLOGY (2015)
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
Frank P. Brouwers et al.
EUROPEAN HEART JOURNAL (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure
Anthony G. Garcia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction
Chiara Lazzeri et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2011)
Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
Jinhua Li et al.
DIABETES (2010)
Adiponectin Deficiency, Diastolic Dysfunction, and Diastolic Heart Failure
Flora Sam et al.
ENDOCRINOLOGY (2010)
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Elisabeth M. Zeisberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease
Steven G. Coca et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The myofibroblast in wound healing and fibrocontractive diseases
G Gabbiani
JOURNAL OF PATHOLOGY (2003)
分享论文
